eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Abstracting and indexing Subscription
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2010
vol. 6
 
Share:
Share:
abstract:

Original research
Screening for coeliac disease among Egyptian children

Soha M. Abd El Dayerm
,
Azza Ahmed Aly
,
Esmat Abd El Gafar
,
Hesham Kamel

Arch Med Sci 2010; 6, 2: 226-235
Online publish date: 2010/04/30
View full text Get citation
 
Introduction: To screen for coeliac disease in Egyptian children with non-endocrinal short stature, refractory iron deficiency anaemia and type 1 diabetes. Also, to evaluate the sensitivity and specificity of different serological tests for diagnosis of coeliac disease (CD).
Material and methods: The study included 292 patients with clinical risk of CD. Testing for coeliac antibodies was performed, together with upper gastro­intestinal endoscopy and small intestinal biopsy.
Results: Eleven patients (44%) among 25 patients with refractory iron deficiency anaemia, 23 patients (34.3%) among 67 patients with non-endocrinal short stature, and 6 patients (3%) among 200 patients with type I diabetes mellitus were diagnosed by jejunal biopsy as having coeliac disease. AGA (IgG) had the highest sensitivity for diagnosing CD (80.0%) followed by the TTG (72.7%) antibody, while ARA had the highest specificity (95.9%) followed by anti-EMA (94.7%).
Conclusions: Coeliac disease is more common in Egyptian children with refractory iron deficiency anaemia, non-endocrinal short stature and type 1 diabetes than was previously thought; therefore it is mandatory to screen such patients for CD. Serological tests showed fairly good sensitivity and specificity for the diagnosis; however, intestinal biopsy remains the cornerstone for definitive diagnosis of patients with immunological reaction to gluten.
keywords:

coeliac disease, short stature, insulin-dependent diabetes mellitus, refractory iron deficiency anaemia

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.